nobiletin has been researched along with Angiogenesis, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darvin, P; Kang, DY; Kim, DH; Kim, HJ; Lee, HG; Park, JH; Park, YM; Sp, N; Yang, YM | 1 |
| Ikeda, M; Ikekita, M; Kunimasa, K; Kuranuki, S; Ohta, T; Oikawa, T; Sato, M; Yamori, Y | 1 |
| Chang, CD; Liao, MH; Lin, PY; Shih, WL; Wu, HY; Yu, FL | 1 |
3 other study(ies) available for nobiletin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.
Topics: Adenocarcinoma; Base Sequence; Breast Neoplasms; CD36 Antigens; Cell Line, Tumor; Cell Movement; Cell Survival; Computer Simulation; DNA; Female; Flavones; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Protein Binding; STAT3 Transcription Factor | 2018 |
Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Topics: Animals; Antioxidants; Blotting, Northern; Blotting, Western; Cell Line; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Precursors; Fibroblast Growth Factor 2; Flavones; Gene Expression; Humans; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Neovascularization, Physiologic; Plasminogen Activators; Signal Transduction; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2010 |
Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flavones; Fluorescent Antibody Technique; Glucose-6-Phosphate Isomerase; Humans; Immunoprecipitation; Liver Neoplasms; Luciferases; Lung Neoplasms; Male; Matrix Metalloproteinase 3; Mice; Mice, Nude; Neovascularization, Pathologic; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction; Transforming Growth Factor beta; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2013 |